Sulfonylureas Market

Sulfonylureas are a class of drugs that are used to treat type 2 diabetes. Sulfonylureas function by decreasing blood glucose levels and increasing the secretion of insulin from the pancreas' beta cells. Sulfonylureas do not operate in patients with type 1 diabetes because their effect is dependent on the presence of active beta cells. Sulfonylureas promote insulin release by inhibiting ATP-sensitive potassium channels by lowering potassium permeability in beta cells. This causes the cell to depolarize and enhance calcium entry, resulting in an increase in insulin secretion.

Data Bridge Market Research analyses that the sulfonylureas market was valued at USD 6,600.44 million in 2021 and is expected to reach USD 8,485.43 million by 2029, registering a CAGR of 3.19% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Get PDF Sample:-

Sulfonylureas Market Dynamics


  • Rise in the prevalence of type 2 diabetes across the globe

The rising prevalence of type 2 diabetes across the globe is a major factor driving the sulfonylureas market's growth rate. Sulfonylureas are usually the second line of treatment for type 2 diabetes patients. In recent years, the global diabetic population has exploded, with type 2 diabetes accounting for about 90% of all diabetics.

  • Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of sulfonylureas market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.

  • Growing number of geriatric populations

The rising geriatric population is expected to enhance the growth rate of sulfonylureas market. Sulfonylureas are generally used as a last alternative for people with type 2 diabetes. The global diabetic population has grown in recent years, with type 2 diabetes accounting for about 90% of all diabetics. As people get older, the prevalence of type 2 diabetes rises, as does the risk of coronary heart disease, vascular illness, and stroke. Patients with diabetes who are older are at a higher risk of sarcopenia and physical impairment.

Furthermore, rising initiatives by public and private organizations to spread awareness will expand the sulfonylureas market. Additionally, changing lifestyle of people and increasing incidences of obesity will result in the expansion of sulfonylureas market.


  • Increase in the number of research and development activities

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the sulfonylureas market growth. Along with this, rising drug approvals and launches will further propel the market's growth rate. The advent of new and more efficient diabetic treatment and monitoring products is estimated to boost the market's growth rate in the future. 

Global Sulfonylureas Market Scope

The sulfonylureas market is segmented on the basis of drugs, indication, dosage form, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.


  • Glyburide
  • Glipizide
  • Glimepiride
  • Others


  • Diabetes
  • Others

Dosage form

  • Tablets
  • Capsules
  • Others

Route of Administration

  • Oral
  • Others


  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Get TOC details of the Report: -

Competitive Landscape and Sulfonylureas Market Share Analysis

The Sulfonylureas market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to sulfonylureas market.

Some of the major players operating in the sulfonylureas market are:

  • Amneal Pharmaceuticals LLC. (US)
  • Reddy's Laboratories Ltd. (India)
  • AstraZeneca (UK)
  • Johnson & Johnson Private Limited (US)
  • Bausch Health Companies Inc. (Canada)
  • Eli Lilly and Company (US)
  • AbbVie Inc. (US)
  • Abbott (US)
  • Hoffmann-La Roche Ltd. (Switzerland)
  • Mylan N.V. (US)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Sanofi (France)
  • Novartis AG (Switzerland)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Aurobindo Pharma (India)
  • Lupin (India)
  • Allergan (Ireland)
  • Merck & Co., Inc. (US)
  • Pfizer Inc. (US)
  • GlaxoSmithKline plc (UK)
  • Zydus Cadila (India)
  • Hikma Pharmaceuticals PLC (UK)
  • Cipla Inc. (US)
  • Apotex Inc. (Canada)

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.

Browse in-depth Research Report:-

Related Reports: -

About Data Bridge Market Research, Private Ltd

Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.

Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”


Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475